Northern Trust Portfolio holdings
AUM $727B
1-Year Return
23.08%
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
This Quarter Return
-2.45%
1 Year Return
+23.08%
3 Year Return
+97.56%
5 Year Return
+177.34%
10 Year Return
+414.74%
AUM
$674B
AUM Growth
-$32.7B
(-4.6%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-0.2%
Top 10 Holdings %
Top 10 Hldgs %
25.64%
Holding
4,571
New
130
Increased
1,586
Reduced
2,464
Closed
154
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$741M |
| 2 |
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
|
+$363M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$355M |
| 4 |
Visa
V
|
+$255M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$210M |
Top Sells
| 1 |
Apple
AAPL
|
+$655M |
| 2 |
Microsoft
MSFT
|
+$468M |
| 3 |
Illinois Tool Works
ITW
|
+$375M |
| 4 |
NVIDIA
NVDA
|
+$371M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$273M |
Sector Composition
| 1 | Technology | 26.34% |
| 2 | Financials | 13.03% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3451
MacroGenics
MGNX
$98.6M
| $662K | ﹤0.01% |
521,269
-19,701
| -4% | -$25K |
|
3452
VictoryShares US 500 Volatility Wtd ETF
CFA
$532M
| $662K | ﹤0.01% |
7,837
| – | – |
|
3453
First US Bancshares
FUSB
$69.7M
| $660K | ﹤0.01% |
49,372
+24,728
| +100% | +$330K |
|
3454
Solid Biosciences
SLDB
$428M
| $658K | ﹤0.01% |
177,898
+8,798
| +5% | +$32.6K |
|
3455
iShares Core MSCI Pacific ETF
IPAC
$1.93B
| $658K | ﹤0.01% |
10,565
| – | – |
|
3456
iShares MSCI ACWI ex US ETF
ACWX
$6.84B
| $657K | ﹤0.01% |
11,852
-105,056
| -90% | -$5.83M |
|
3457
Adverum Biotechnologies
ADVM
$64.4M
| $657K | ﹤0.01% |
150,372
-2,205
| -1% | -$9.64K |
|
|
SMC
3458
Summit Midstream Corporation
SMC
$277M
| $657K | ﹤0.01% |
19,387
+408
| +2% | +$13.8K |
|
3459
iShares Core High Dividend ETF
HDV
$11.6B
| $656K | ﹤0.01% |
5,413
-598
| -10% | -$72.4K |
|
3460
Atossa Therapeutics
ATOS
$106M
| $655K | ﹤0.01% |
973,998
-51,726
| -5% | -$34.8K |
|
3461
BayFirst Financial Corp
BAFN
$35.4M
| $655K | ﹤0.01% |
39,136
+21,728
| +125% | +$364K |
|
|
NOAH
3462
Noah Holdings
NOAH
$771M
| $649K | ﹤0.01% |
68,630
-21,628
| -24% | -$204K |
|
3463
Soho House & Co
SHCO
$1.73B
| $649K | ﹤0.01% |
104,937
-1,418
| -1% | -$8.76K |
|
3464
Virgin Galactic
SPCE
$189M
| $646K | ﹤0.01% |
213,303
-9,450
| -4% | -$28.6K |
|
3465
Caesarstone
CSTE
$48.4M
| $643K | ﹤0.01% |
264,748
-22,319
| -8% | -$54.2K |
|
3466
FlexShares Credit-Scored US Long Corporate Bond Index Fund
LKOR
$43.9M
| $642K | ﹤0.01% |
15,124
-3,359
| -18% | -$143K |
|
3467
SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$11.4B
| $640K | ﹤0.01% |
9,409
-5,179
| -36% | -$352K |
|
3468
iShares MSCI Agriculture Producers ETF
VEGI
$91.6M
| $638K | ﹤0.01% |
17,212
| – | – |
|
3469
Northern Technologies International Corp
NTIC
$73.4M
| $638K | ﹤0.01% |
61,245
-1,320
| -2% | -$13.7K |
|
3470
Tilray
TLRY
$1.32B
| $637K | ﹤0.01% |
968,691
-80,667
| -8% | -$53K |
|
3471
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$15.1B
| $637K | ﹤0.01% |
12,463
-1,513
| -11% | -$77.3K |
|
3472
Biomea Fusion
BMEA
$117M
| $634K | ﹤0.01% |
297,585
-25,065
| -8% | -$53.4K |
|
3473
Nuveen Municipal Credit Income Fund
NZF
$2.4B
| $633K | ﹤0.01% |
51,723
+26,146
| +102% | +$320K |
|
3474
InflaRx
IFRX
$83.3M
| $631K | ﹤0.01% |
618,903
-47,942
| -7% | -$48.9K |
|
3475
Fate Therapeutics
FATE
$110M
| $628K | ﹤0.01% |
794,973
-10,545
| -1% | -$8.33K |
|